Healthcare and Life Sciences in North America: Opportunities & Post-Pandemic Outlook December 12, 2022 Life Science
H1 2022 Healthcare and Life Sciences Worldwide: Cell and Gene Therapy (CGT) December 6, 2022 Life Science
H1 2022 Healthcare and Life Sciences in North America: Market Insights November 29, 2022 Life Science
Digital Solutions and Data Service for Clinicians Worldwide – Think Research July 19, 2022 Life Science
Looking for your next +30% opportunity? Join our multi-sector high growth stock virtual event October 27, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Confirms OTCQB Application is Filed October 19, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer October 14, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain October 4, 2021 Cannabis, Consumer Goods, Life Science, Technology
Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference September 30, 2021 Life Science
Hemostemix Announces Closing of First Tranche of Unit Private Placement September 21, 2021 Life Science
Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years September 14, 2021 Life Science
Hemostemix Provides Update of Phase II Clinical Trial, 9th Circuit Court Decision Including Cost Award and its Annual General Meeting Results July 6, 2021 Life Science
